The healthcare industry is fundamentally supported by cutting-edge technological advancements and scientific breakthroughs. Notably, liposome technology is being developed as a viable innovation in drug delivery systems. Drugs delivered by using liposomes have showcased considerable promise against numerous health conditions such as microbial infections, cancer, enzyme or hormone deficiencies, gene malfunction, and metal detoxification among other chronic disorders. The application of liposomes in cancer treatment is especially prominent as it can help combat a mounting healthcare challenge. Over 18.1 million suffered from cancer in 2020 globally. The key to liposomes’ feasibility in the healthcare domain is their outstanding biodegradability and biocompatibility. The growing burden of chronic diseases and other disorders, coupled with paced medical science innovations pertaining to liposomes are expected to fuel the long-term growth of the global liposome drug delivery market.
For More Industry Insight Read:
Paced Demand for Liposomal Doxorubicin Formulation to Unlock New Avenues of Growth for Liposome Drug Delivery Market
As liposome drug delivery systems continue to reap benefits, more healthcare providers are expected to leverage this game-changing technique. For instance, liposomal doxorubicin is actively being used for treating several types of cancer. Healthcare industry stakeholders are directing significant research and development funds to explore the efficacy of liposomal doxorubicin formula in treating breast and ovarian cancer. The prevalence of sedentary lifestyles, stress, and other harmful habits are also indirectly contributing to the sales of liposomal doxorubicin. The application in cancer treatment, coupled with the presence of other positive market factors is poised to create robust growth possibilities for the global liposome drug delivery market.
Incessant Growth in Occurrence of Chronic Illnesses to Maintain Healthy Growth Trajectory of Liposome Drug Delivery Market
In the past few years, the number of chronic disease cases has proliferated at an alarming pace, thereby contributing to the growth in the global liposome drug delivery market. Many including pharmaceutical players, healthcare regulatory bodies, and government organisations are directing their R&D efforts to tackle these healthcare challenges. Against this backdrop, liposomal drugs are being employed owing to their advantages including improved pharmacokinetics and pharmacodynamics, higher drug efficacy, and lower toxicity. This medical tech advancement is expected to help contain the growing prevalence of chronic illnesses such as cancer. Polymers are key to developing carriers for cancer therapy and liposomal drug delivery helps improve cancer treatment.
Presence of Sophisticated Healthcare Infrastructure to Cement North America’s Lead in Liposome Drug Delivery Market
The increasing occurrence of cancer and other chronic diseases coupled with the presence of a robust healthcare industry is cementing North America as the leading liposome drug delivery market. Consumers have notable awareness of healthcare and novel treatment therapeutics across North America. Major economies such as the USA have a significant geriatric population which is a key end-user segment of liposome drug delivery. Growing demand for non-invasive drug delivery and focused R&D initiatives by pharmaceutical players are also assisting the regional market growth.
Major Market Players
Some of the leading players in the global liposome drug delivery market include Novartis AG, Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc., Pacira BioSciences, Inc., Ipsen Pharma, Takeda Pharmaceutical Company Limited, Luye Pharma Group, Astellas Pharma, Inc., Celsion Corporation, and Johnson & Johnson.
Get Sample/Toc Copy Of Report:
Latest Trending Reports:
- Quillaja Extract Market Size, Analysis, Share, Research, Business Growth and Forecast to 2030: https://www.openpr.com/news/2947354/quillaja-extract-market-size-analysis-share-research
- Payment Security Market Analysis, Key Players, Industry Insights, Opportunity and Forecast to 2030: https://www.openpr.com/news/2947356/payment-security-market-analysis-key-players-industry
- Bio LPG Market is Expected to Witness a Rise of CAGR 47% During 2020 to 2025: https://www.openpr.com/news/2945434/bio-lpg-market-is-expected-to-witness-a-rise-of-cagr-47-during-2020
- Synthetic Artificial Blood Vessels Market Size Set for Healthy Expansion at a CAGR of 5.7% Through 2026: https://www.openpr.com/news/2945407/synthetic-artificial-blood-vessels-market-size-set-for-healthy
- Vaccines Market to Reach US$54,684.8 Mn, Globally, by 2025 at 10.2% CAGR: Fairfield Market Research: https://www.openpr.com/news/2945386/vaccines-market-to-reach-us-54-684-8-mn-globally-by-2025
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Follow Us: LinkedIn